Cargando…
Efficacy predictors of a second tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis
To retrospectively evaluate initial tumor necrosis factor inhibitor (TNFi) failure patients for clinical predictors of response to a 2nd TNFi in our 4282 rheumatoid arthritis (RA) patient database. A cross-sectional retrospective manual chart review of the electronic health record (EHR) was performe...
Autores principales: | Reams, Jennifer, Berger, Andrea, Denio, Alfred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458252/ https://www.ncbi.nlm.nih.gov/pubmed/32871905 http://dx.doi.org/10.1097/MD.0000000000021827 |
Ejemplares similares
-
Comparative efficacy and safety of JAK inhibitors and leflunomide in rheumatoid arthritis: A protocol for systematic review and meta-analysis
por: Zhang, Xiaogang, et al.
Publicado: (2022) -
Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
por: Ma, Zeren, et al.
Publicado: (2017) -
The efficacy of statins in the treatment of rheumatoid arthritis: A systematic review and meta-analysis
por: Ren, Conglin, et al.
Publicado: (2023) -
Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Lyu, Qian, et al.
Publicado: (2023) -
Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)